It's the oldest single-tablet regimen for HIV. But is it washed up as a viable treatment option? Here's a top expert's take.
It’s not considered a “preferred” option for starting HIV treatment in the U.S., but Genvoya still has its place in our medication arsenal.
What makes this two-drug regimen for HIV so unique? An expert HIV clinician walks us through the details.
Get an HIV doc's rundown of the most important info to understand about this three-drug, single-tablet regimen.
A top-notch HIV doctor dishes the details on one of the U.S.'s recommended first-line HIV treatment drugs.
Michael Broder explores the decades-long journey from experimental treatments for herpes to COVID-19, with HIV along the way.
Superinfection—when someone living with HIV is infected with a second strain of the virus—is a scary prospect. But is it a concern in the era of modern HIV treatment?
An expert HIV doctor explains viral load testing, what "undetectable" and "unquantifiable" really mean, and how to make sense of your latest numbers.
Recently, my doctor ordered this resistance test. When the results came back, it stated that the test could not be performed, probably because sufficient DNA could not be collected. A repeat test was performed and the same non-results came back. I ha...
I live outside the US and cant afford genvoya monthly. How dangerous scientifically speaking would it be to tak Genvoya every other day. I have to pay cash and It is very expensive. Thankyou Saki